Response of blood pressure after percutaneous transluminal renal artery angioplasty and stenting

Table 1 Baseline characteristics of study population: Clinical, laboratory and imaging data n (%)

Variables	n = 86
Male gender	67 (77.9)
Age (yr)	55.87 ± 11.85
Background diseases
Stage-1 (malignant) hypertension	14 (16.3)
Stage-2 hypertension	65 (75.6)
Diabetes mellitus	34 (39.5)
Smoking	61 (70.9)
Clinical features of left ventricular dysfunction	23 (26.7)
Left ventricular hypertrophy	29 (33.7)
Coronary artery disease	72 (83.7)
Blood pressure
Systolic (mmHg)	170.15 ± 20.10
Diastolic (mmHg)	98.38 ± 10.55
Antihypertensive drugs (n)	3.07 ± 0.69
Indication criteria
Hypertension resistant to standard medication	71 (82.6)
Renal bruit	53 (61.6)
Serum creatinine (mg/dL)	20 (23.3)
Stenosis
Bilateral	23 (26.7)
Coronary angiography
Single vessel disease	25 (29.1)
Double vessel disease	14 (16.3)
Triple vessel disease	28 (32.6)
Normal vessel	19 (22.1)

Values are presented as percentage (%) and mean ± SD.